Anti-CD3 epsilon antibody [SP7] (Ab16669)

Anti-CD3 epsilon antibody [SP7] (ab16669) was developed by Abcam using patented rabbit monoclonal antibody technology and is validated for use in Flow Cyt (Intra), IHC-P, WB and mIHC. Anti-CD3 epsilon antibody [SP7] (ab16669) was first used in a scientific publication in 2008 and has been cited over 722 times in peer reviewed journals. It's performance in IHC in human, mouse and rat samples is trusted by the scientific community. Abcam's high quality manufacturing and validation processes ensure Anti-CD3 epsilon antibody [SP7] (ab16669) has high sensitivity and specificity alongside high lot-to-lot consistency and reproducibility. Anti-CD3 epsilon antibody [SP7] (ab16669) has 79 independent reviews from customers. Anti-CD3 epsilon antibody [SP7] (ab16669) specifically detects CD3 epsilon (UniProt ID: P07766; Molecular weight: 21kDa) and is sold in a convenient trial size to enable initial testing (20 µL) and larger sizes for subsequent scaling up experiments (100 µL, 500 µL and 1 mL). Conjugation-ready, carrier free format available for antibody clone SP7 - ab205228. Anti-CD3 epsilon antibody [SP7] (ab16669) is a clone from the portfolio of Spring Bioscience (Roche) SP clones which have been optimised for immunohistochemistry (IHC). Top cited recombinant antibody on the market with >988 citations. SP7 has received >79 reviews. CD3 epsilon (CD3ε) is a crucial component of the T-cell receptor (TCR) complex. It plays a key role in T-cell activation and signal transduction by coupling antigen recognition to intracellular signalling pathways. What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies.